As you can see SR you've ditectly raised several valid points for discussion, yet the DV avoids engaging any of them, moreover deflects discussion or redirect it to some other unrelated matter. Oh yes, the DV wants discussion, but only on DV crap that has been done to death. Lets face it, a one-trick-pony and not astute or erudite one at that, which accounts for why so many have chosen to apply the HC IGNORE feature to the DV.
So back to specifics, I think this dude would be good to have a chat in a bar, Nathan Butlin. Or at the AACC Clinical Lab Expo in a couple of days
Ann: AnteoTech Developing Multiplex Test for COVID-19, page-399
-
- There are more pages in this discussion • 370 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $54.77M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.2¢ | 2.0¢ | $12.70K | 583.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1191253 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 520012 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |